Try our Advanced Search for more refined results
January 18, 2022
IN RE: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 06, 2024
Judge May Sit In On Depos In Abbott Formula MDL
An Illinois federal judge overseeing multidistrict litigation in which Abbott Laboratories' Similac infant formula is alleged to have caused a deadly illness in premature babies said Wednesday she would hold off on appointing a special master following claims of improper deposition conduct, offering to tune in to depositions to help move things along.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login